December 2023 Price Concessions 3rd and Final Update


UPDATE 12th January 2024: Improved price for Ezetimibe and further price concessions granted for December 2023

The 3rd price concession update published below on 22 December 2023 is the final update for the month. There are no further price concessions to announce for the month of December. However, Community Pharmacy England has queried some of prices imposed by DHSC and we are currently awaiting their response. If granted, any price adjustments will be notified on our website as soon we receive confirmation from the Department. 

During the month of December 2023, Community Pharmacy England also received several reports from pharmacy owners unable to obtain Riluzole 50mg tablets at the published Drug Tariff price. We submitted requests for a price concession, but this was later withdrawn after confirmation from DHSC that, due to the price change mechanism, the actual reimbursement price for Riluzole 50mg tablets (56) had increased to £300.23 for the month of December 2023.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/12/2023) announced the following final list of price concessions for December 2023. Please note this is the final list for December 2023.

Drug Pack size Price concession
Aripiprazole 10mg tablets 28 £16.65
Aripiprazole 15mg tablets 28 £16.77
Benzoyl peroxide 5% / Clindamycin 1% gel 30 £11.90
Clarithromycin 250mg/5ml oral suspension 70 £5.80
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £1.99
Co-codamol 30mg/500mg capsules 100 £5.42
Donepezil 5mg tablets 28 £1.50
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 5 £4.17
Duloxetine 20mg gastro-resistant capsules 28 £7.04
Eplerenone 25mg tablets 28 £6.43
Esomeprazole 40mg gastro-resistant capsules 28 £2.45
Estradiol 10microgram pessaries 24 £9.45
Etoricoxib 30mg tablets 28 £3.04
Ezetimibe 10mg tablets 28 £9.44
Frovatriptan 2.5mg tablets 6 £10.92
Hydrocortisone 10mg tablets 30 £2.13
Lorazepam 500microgram tablets 28 £21.48
Mercaptopurine 50mg tablets 25 £8.77
Metoclopramide 10mg tablets 28 £2.19
Metoprolol 50mg tablets 28 £2.75
Mometasone 50micrograms/dose nasal spray 140 £4.79
Morphine sulfate 10mg/1ml solution for injection ampoules 10 £4.70
Mycophenolate mofetil 500mg tablets 50 £6.47
Ondansetron 4mg tablets 10 £3.14
Paracetamol 500mg effervescent tablets 100 £8.26
Primidone 250mg tablets 100 £86.65
Prochlorperazine 3mg buccal tablets 50 £8.67
Quinine sulfate 300mg tablets 28 £3.95
Rizatriptan 10mg orodispersible tablets sugar free 3 £8.11
Ropinirole 500microgram tablets 28 £15.75
Rosuvastatin 20mg tablets 28 £1.92
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules 20 £9.50
Sodium cromoglicate 2% eye drops 13.5 £2.35
Tacrolimus 0.1% ointment 30 £19.16
Tacrolimus 0.1% ointment 60 £38.32

For the full list of price concessions granted for December 2023, please visit our webpage: Please  subscribe to our mailing list to receive email updates of any price concessions.

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

Further information on price  concessions and FAQs about the process  involved  can be found on our website ( To hear more on how the current price  concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar  here.

Improvements to the price concession system

Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by  DHSC  in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.

One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.